Ownership history in MACQUARIE GROUP LTD · 22 quarters on record
This page tracks every 13F SEC filing in which MACQUARIE GROUP LTD reported a position in AXSOME THERAPEUTICS INC (AXSM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 1,084,536 | -53,212 | -4.7% | 0.15% | $131.7M | $121.45 |
| 2025 Q2 | ADDED | 1,137,748 | +161,488 | +16.5% | 0.15% | $118.8M | $104.39 |
| 2025 Q1 | ADDED | 976,260 | +12,213 | +1.3% | 0.15% | $113.9M | $116.63 |
| 2024 Q4 | REDUCED | 964,047 | -31,240 | -3.1% | 0.10% | $81.6M | $84.61 |
| 2024 Q3 | REDUCED | 995,287 | -77,955 | -7.3% | 0.10% | $89.4M | $89.87 |
| 2024 Q2 | ADDED | 1,073,242 | +372,832 | +53.2% | 0.10% | $86.4M | $80.50 |
| 2024 Q1 | ADDED | 700,410 | +672,886 | +2444.7% | 0.06% | $55.9M | $79.80 |
| 2023 Q4 | ADDED | 27,524 | +6,009 | +27.9% | 0.00% | $2.2M | $79.59 |
| 2023 Q3 | REDUCED | 21,515 | -24,576 | -53.3% | 0.00% | $1.5M | $69.89 |
| 2023 Q2 | ADDED | 46,091 | +26,187 | +131.6% | 0.00% | $3.3M | $71.86 |
As of 2025 Q4 — sorted by position size